Searched for
GENERIC ANTIBIOTICS PRODUCTION FUNDING
Middle class, aspirational consumers to drive 93% of India's spending by 2036: SitharamanIndia's middle class is poised to fuel significant economic expansion, with 93% of all spending expected to originate from this segment by ...- Death in a vial: Five cases lay bare many uncomfortable truths about Indian healthcareFive young mothers in Kota died after childbirth, with suspicion falling on oxytocin injections. Investigations revealed the vials containe...
- Indian envoy pitches greater pharma exports, Chinese investment to deepen tiesIndia's ambassador to China, Vikram Doraiswami, stressed the importance of expanding access to Chinese markets for Indian pharmaceutical co...
- The Wealth Company Asset Management announces appointment of Unmesh Kulkarni as managing directorThe Wealth Company, part of Pantomath Group, has appointed Unmesh Kulkarni as its Managing Director. With 29 years of experience in wealth ...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...
- JioBlackRock to offer full MF bouquet in 3 years; plans more SIFs, ETFs, GIFT City productsJio BlackRock is set to significantly expand its mutual fund offerings over the next three years, venturing into more specialized investmen...
- For low risk-takers: 5 large-caps from different sectors with an upside potential of up to 31%Now, there is nothing wrong with being bullish, because it has always paid to be bullish. Yes, one might argue that it has not paid in the ...
- Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
- NuVentures invests in the US-based LinqAlpha, an AI-powered investment research firmFounded by former MIT PhDs and Golman Sachs Analysts Jacon Choi, Subeen Pang, Jin Kim, and Hojun Choi in 2023, the startup uses AI agents t...
- Why CDSCO and BEE have not kept pace with the industries they overseeCDSCO still faces challenges like chronic understaffing, gaps in technical skills, weak lab infra and fragmented approvals. About a decade ...
- India initiates anti-dumping probes against five products from China, other nationsThe five items are moulded soda-lime glass vials; electric tractors in 6x4 and 4x2 axle configuration in any form; cyanuric chloride; polye...
- Sore throat or tonsillitis? Symptoms, causes, why infections keep coming back and new treatment options explainedRecurring sore throats and difficulty swallowing might signal tonsillitis, an inflammation of the tonsils. With growing antibiotic resistan...
- Alembic Pharmaceuticals gets USFDA nod for generic acne treatment gelAlembic Pharmaceuticals has secured final USFDA approval for its generic Dapsone gel, a topical treatment for acne vulgaris. This approval,...
- At Sid's Farm, a quality-first approach sets the standard.Sid's Farm is strengthening consumer trust through rigorous daily quality checks and a parent-first approach to dairy production. The compa...
- For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
- India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...
- Biosimilars and innovation will drive Indian pharma's next growth phase: Vishal ManchandaIndia's pharmaceutical sector is pivoting beyond generics, with companies aggressively pursuing growth in biosimilars, nutraceuticals, and ...
- 16 fixed-dose combination drugs banned in India: Check full list hereFixed dose combination banned full list: India has banned 16 fixed-dose combination drugs, including certain antibiotics and antispasmodics...
- India bans 16 fixed-dose drug combinations over safety concernsIn a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...
Load More
